Australia markets closed

The PNC Financial Services Group, Inc. (PNC)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
173.26-5.22 (-2.92%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous close178.48
Open180.30
Bid0.00 x 1100
Ask177.56 x 800
Day's range173.20 - 180.85
52-week range79.41 - 180.85
Volume1,793,169
Avg. volume1,984,736
Market cap73.462B
Beta (5Y monthly)1.35
PE ratio (TTM)10.21
EPS (TTM)16.97
Earnings date16 Apr 2021
Forward dividend & yield4.60 (2.65%)
Ex-dividend date15 Jan 2021
1y target est164.68
  • Harris Williams Advises Chequers Capital on its Acquisition of 7days
    Business Wire

    Harris Williams Advises Chequers Capital on its Acquisition of 7days

    Harris Williams, a global investment bank specializing in M&A advisory services, announces it advised Chequers Capital on its acquisition of 7days, a portfolio company of Silverfleet Capital (Silverfleet). 7days is a leading direct-to-consumer supplier of fashionable workwear for medical professionals. The transaction was led by professionals from the Harris Williams Consumer Group, including Andreas Poth and Konstantin Molinari of the firm’s Frankfurt office, Ed Arkus of the firm’s London office and Corey Benjamin of the firm’s Richmond office.

  • Early Warning Services and The Clearing House Now Enable Zelle® Payments on the RTP® Network
    PR Newswire

    Early Warning Services and The Clearing House Now Enable Zelle® Payments on the RTP® Network

    Early Warning Services, LLC and The Clearing House (TCH) today announced Zelle® transactions can now be cleared and settled over the RTP® network.

  • Harris Williams Advises Altasciences on its Pending Sale to Novo Holdings A/S
    Business Wire

    Harris Williams Advises Altasciences on its Pending Sale to Novo Holdings A/S

    Harris Williams, a global investment bank specializing in M&A advisory services, announces it is the lead advisor to Altasciences, a portfolio company of Audax Private Equity, on its pending sale to Novo Holdings A/S (Novo Holdings). Founded in 1992, Altasciences is a fully integrated, early drug development services platform, providing the pharma and biotech industries with a trusted partner for drug development, from preclinical safety testing through to clinical proof-of-concept studies. The transaction is being led by Paul Hepper, Geoffrey Smith, Tyler Bradshaw, Miles Annin and Bill Whitaker of the Harris Williams Healthcare & Life Sciences (HCLS) Group and Daniel Wang, a managing director leading the firm’s efforts in Asia.